Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome
- PMID: 31647191
- PMCID: PMC6954712
- DOI: 10.1002/sctm.19-0205
Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome
Abstract
Acute respiratory distress syndrome (ARDS) is a serious and potentially fatal acute inflammatory lung condition which currently has no specific treatments targeting its pathophysiology. However, mesenchymal stem cells have been shown to have very promising therapeutic potential, and recently, it has been established that their effect is largely due to the transfer of extracellular vesicles (EVs). EVs have been shown to transfer a variety of substances such as mRNA, miRNA, and even organelles such as mitochondria in order to ameliorate ARDS in preclinical models. In addition, the fact that they have been proven to have the same effect as their parent cells combined with their numerous advantages over whole cell administration means that they are a promising candidate for clinical application that merits further research.
Keywords: cellular therapy; clinical translation; mesenchymal stem cells (MSCs); respiratory tract.
© 2019 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.
Conflict of interest statement
The authors declared no potential conflict of interest.
Figures
Comment in
- 
  
  In reply.Stem Cells Transl Med. 2020 Jul;9(7):815-816. doi: 10.1002/sctm.20-0112. Epub 2020 Apr 22. Stem Cells Transl Med. 2020. PMID: 32320529 Free PMC article. No abstract available.
- 
  
  Mesenchymal stem cells as a potential treatment for critically ill patients with coronavirus disease 2019.Stem Cells Transl Med. 2020 Jul;9(7):813-814. doi: 10.1002/sctm.20-0083. Epub 2020 Apr 22. Stem Cells Transl Med. 2020. PMID: 32320535 Free PMC article. No abstract available.
References
- 
    - Ashbaugh D, Bigelow DB, Petty T, Levine B. Acute respiratory distress in adults. Lancet. 1967;290:319‐323. - PubMed
 
- 
    - Force AD, Ranieri VM, Rubenfeld GD. Acute respiratory distress syndrome. JAMA. 2012;307:2526‐2533. - PubMed
 
- 
    - Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA. 2018;319:698‐710. - PubMed
 
- 
    - Máca J, Jor O, Holub M, et al. Past and present ARDS mortality rates: a systematic review. Respir Care. 2017;62:113‐122. - PubMed
 
- 
    - Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364:1293‐1304. - PubMed
 
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
         
              